Literature DB >> 19687154

In vivo myocardial distribution of multipotent progenitor cells following intracoronary delivery in a swine model of myocardial infarction.

Hung Q Ly1, Kozo Hoshino, Irina Pomerantseva, Yoshiaki Kawase, Ryuichi Yoneyama, Yoshiaki Takewa, Annik Fortier, Summer L Gibbs-Strauss, Carrie Vooght, John V Frangioni, Roger J Hajjar.   

Abstract

AIMS: There are few data comparing the fate of multipotent progenitor cells (MPCs) used in cardiac cell therapy after myocardial infarction (MI). To document in vivo distribution of MPCs delivered by intracoronary (IC) injection. METHODS AND
RESULTS: Using an anterior MI swine model, near-infrared (NIR) fluorescence was used for in vivo tracking of labelled MPCs [mesenchymal stromal (MSCs), bone marrow mononuclear (BMMNCs), and peripheral blood mononuclear (PBMNCs)] cells early after IC injection. Signal intensity ratios (SIRs) of injected over non-injected (reference) zones were used to report NIR fluorescence emission. Following IC injection, significant differences in mean SIR were documented when MSCs were compared with BMMNCs [1.28 +/- 0.10 vs. 0.77 +/- 0.11, P < 0.001; 95% CI (0.219, 0.805), respectively] or PBMNCs [1.28 +/- 0.10 vs. 0.80 +/- 0.14, P = 0.005; 95% CI (0.148, 0.813), respectively]. Differences were maintained during the 60 min tracking period, with only the MSC-injected groups continuously emitting NIR fluorescence (SIR>1). This is correlated with greater cell retention for MSCs relative to mononuclear cells. However, there was evidence of MSC-related vessel plugging in some swine.
CONCLUSION: Our in vivo NIR fluorescence findings suggest that MPC distribution and retention immediately after intracoronary delivery vary depending on cell population and could potentially impact the clinical efficacy of cardiac cell therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19687154      PMCID: PMC2785946          DOI: 10.1093/eurheartj/ehp322

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  35 in total

Review 1.  Fluorescence-enhanced, near infrared diagnostic imaging with contrast agents.

Authors:  Eva M Sevick-Muraca; Jessica P Houston; Michael Gurfinkel
Journal:  Curr Opin Chem Biol       Date:  2002-10       Impact factor: 8.822

Review 2.  Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging.

Authors:  Vasilis Ntziachristos; Christoph Bremer; Ralph Weissleder
Journal:  Eur Radiol       Date:  2002-07-19       Impact factor: 5.315

Review 3.  In vivo near-infrared fluorescence imaging.

Authors:  John V Frangioni
Journal:  Curr Opin Chem Biol       Date:  2003-10       Impact factor: 8.822

4.  Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI).

Authors:  Birgit Assmus; Volker Schächinger; Claudius Teupe; Martina Britten; Ralf Lehmann; Natascha Döbert; Frank Grünwald; Alexandra Aicher; Carmen Urbich; Hans Martin; Dieter Hoelzer; Stefanie Dimmeler; Andreas M Zeiher
Journal:  Circulation       Date:  2002-12-10       Impact factor: 29.690

5.  In vivo near-infrared fluorescence imaging of osteoblastic activity.

Authors:  A Zaheer; R E Lenkinski; A Mahmood; A G Jones; L C Cantley; J V Frangioni
Journal:  Nat Biotechnol       Date:  2001-12       Impact factor: 54.908

6.  Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction.

Authors:  Emerson C Perin; Guilherme V Silva; Joao A R Assad; Deborah Vela; L Maximilian Buja; Andre L S Sousa; Silvio Litovsky; Jing Lin; William K Vaughn; Stephanie Coulter; Marlos R Fernandes; James T Willerson
Journal:  J Mol Cell Cardiol       Date:  2007-10-04       Impact factor: 5.000

7.  Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs.

Authors:  P Richard Vulliet; Melanie Greeley; S Mitchell Halloran; Kristin A MacDonald; Mark D Kittleson
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

8.  Quantitation of brown adipose tissue perfusion in transgenic mice using near-infrared fluorescence imaging.

Authors:  Akira Nakayama; Antonio C Bianco; Chen-Yu Zhang; Bradford B Lowell; John V Frangioni
Journal:  Mol Imaging       Date:  2003-01       Impact factor: 4.488

9.  Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction.

Authors:  Shao-liang Chen; Wu-wang Fang; Fei Ye; Yu-Hao Liu; Jun Qian; Shou-jie Shan; Jun-jie Zhang; Robert Zhao Chunhua; Lian-ming Liao; Song Lin; Jing-ping Sun
Journal:  Am J Cardiol       Date:  2004-07-01       Impact factor: 2.778

10.  An operational near-infrared fluorescence imaging system prototype for large animal surgery.

Authors:  A M De Grand; J V Frangioni
Journal:  Technol Cancer Res Treat       Date:  2003-12
View more
  16 in total

Review 1.  Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step.

Authors:  James D Richardson; Adam J Nelson; Andrew C W Zannettino; Stan Gronthos; Stephen G Worthley; Peter J Psaltis
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

Review 2.  The paracrine effect: pivotal mechanism in cell-based cardiac repair.

Authors:  Simon Maltais; Jacques P Tremblay; Louis P Perrault; Hung Q Ly
Journal:  J Cardiovasc Transl Res       Date:  2010-06-08       Impact factor: 4.132

Review 3.  Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges.

Authors:  Luiza Bagno; Konstantinos E Hatzistergos; Wayne Balkan; Joshua M Hare
Journal:  Mol Ther       Date:  2018-05-25       Impact factor: 11.454

4.  Cortical Bone Stem Cell Therapy Preserves Cardiac Structure and Function After Myocardial Infarction.

Authors:  Thomas E Sharp; Giana J Schena; Alexander R Hobby; Timothy Starosta; Remus M Berretta; Markus Wallner; Giulia Borghetti; Polina Gross; Daohai Yu; Jaslyn Johnson; Eric Feldsott; Danielle M Trappanese; Amir Toib; Joseph E Rabinowitz; Jon C George; Hajime Kubo; Sadia Mohsin; Steven R Houser
Journal:  Circ Res       Date:  2017-09-14       Impact factor: 17.367

5.  Optical spectroscopic imaging for cell therapy and tissue engineering.

Authors:  G Kate Park; Gaon Sandy Kim; Nathaniel S Hwang; Hak Soo Choi
Journal:  Appl Spectrosc Rev       Date:  2017-06-08       Impact factor: 5.917

Review 6.  Emerging roles for integrated imaging modalities in cardiovascular cell-based therapeutics: a clinical perspective.

Authors:  Peter J Psaltis; Robert D Simari; Martin Rodriguez-Porcel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-08       Impact factor: 9.236

Review 7.  Targeted delivery of therapeutic agents to the heart.

Authors:  Susmita Sahoo; Taro Kariya; Kiyotake Ishikawa
Journal:  Nat Rev Cardiol       Date:  2021-01-26       Impact factor: 32.419

8.  A long road for stem cells to cure sick hearts: update on recent clinical trials.

Authors:  Yong Sook Kim; Youngkeun Ahn
Journal:  Korean Circ J       Date:  2012-02-27       Impact factor: 3.243

Review 9.  Cell tracking in cardiac repair: what to image and how to image.

Authors:  Alessandro Ruggiero; Daniel L J Thorek; Jamal Guenoun; Gabriel P Krestin; Monique R Bernsen
Journal:  Eur Radiol       Date:  2011-07-07       Impact factor: 5.315

Review 10.  Bone marrow-derived mesenchymal stem cells for the treatment of heart failure.

Authors:  Takuya Narita; Ken Suzuki
Journal:  Heart Fail Rev       Date:  2015-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.